Montpellier Regional Cancer Institute
ICM, Montpellier Regional Cancer Institute
Structure: Montpellier Regional Cancer Institute
Date: 2016 à 2018
The Montpellier Regional Cancer Institute (ICM) is one of the 18 Cancer Control Centres (CLCC) that make up the UNICANCER group.
As a CLCC, the Institute combines basic, translational and clinical research to develop integrated, patient-centred cancer research. Thus, clinical, translational and technological research, the biometrics unit and the Biological Resource Centre (BRC) are grouped together within a single directorate, the Scientific Directorate.
Clinical Research is carried out with the patient, in compliance with regulations and ethics. Its objective is to advance and improve therapeutic management, care, diagnostic and prevention techniques through the development and implementation of innovative research projects.
The Biometrics unit carries out research, methodological design, registration, randomisation, data entry, data management and statistical analysis missions for ICM projects and other partners. It also responds to recent needs in translational and fundamental research. Both have training, expertise and valorization activities.